19:07 , Apr 20, 2018 |  BC Week In Review  |  Company News

Vigene gains rights to Virovek's AAV production tech

Viral vector production company Vigene Biosciences Inc. (Rockville, Md.) gained exclusive, worldwide rights to adeno-associated virus (AAV) production technology, BAC-to-AAV, from Virovek Inc. (Hayward, Calif.). Under the deal, Virovek will waive license fees for Phase...
00:20 , Mar 30, 2018 |  BioCentury  |  Finance

Heading for Hong Kong

Raising substantially more than planned in a pair of oversubscribed venture rounds gives Hua Medicine Ltd. more breathing room as the Shanghai diabetes company readies itself to be among the first biotechs to list in...
00:16 , Jan 26, 2018 |  BioCentury  |  Finance

Weighing exchanges

Hua Medicine Ltd. is weighing the merits of pursuing an IPO in Hong Kong versus the U.S. ahead of the expected launch of lead candidate dorzagliatin in China. The Shanghai company’s financing strategy will be...
23:02 , Dec 22, 2017 |  BC Extra  |  Company News

Management tracks: CRISPR, Hua

Gene editing company CRISPR Therapeutics AG (NASDAQ:CRSP) appointed Rodger Novak as chairman of the board. He succeeds Tony Coles, who will remain as a senior adviser. Novak is founder and president of CRISPR, and served...
07:00 , Apr 28, 2016 |  BC Innovations  |  Distillery Techniques

Techniques: Transgenic mouse models of human chromosome 9 open reading frame 72 (C9orf72)-mutant amyotrophic lateral sclerosis (ALS) or frontotemporal dementia

Disease models TECHNOLOGY: Transgenics and knockouts Transgenic mice expressing repeat expansions of GGGGCC in human C9orf72 could be used to screen therapies for ALS or FTD. In mice, bacterial artificial chromosome (BAC)-mediated expression of either...
08:00 , Jan 14, 2016 |  BC Innovations  |  Translation in Brief

Modeling ALS

The discovery of a mutation in the chromosome 9 open reading frame 72 (C9orf72) region as the most common genetic cause of amyotrophic lateral sclerosis (ALS) over four years ago has led to new mechanistic...
01:39 , Jan 13, 2016 |  BC Extra  |  Politics & Policy

Coalition aims for cancer MoonShot

Stakeholders including biopharma companies, academic research centers, community oncologists, payer Independence Blue Cross (Philadelphia, Pa.) and Bank of America Corp. (NYSE:BAC) launched the MoonShot 2020 initiative to test combination therapies in immuno-oncology. The initiative said...
07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

PE Applied Biosystems sales and marketing update

PE Applied Biosystems, a unit of The Perkin-Elmer Corp. (Norwalk, Conn.), launched its ABI Prism BigDye Primer Cycle Sequencing Kit for use in bacterial artificial chromosome (BAC-end) sequencing. BigDye chemistry increases the throughput of BAC...
07:00 , Apr 8, 2013 |  BC Week In Review  |  Company News

Immunomedics, Bank of America Corp., Financial Industry Regulatory Authority (FINRA) cancer, autoimmune, diagnostic news

Immunomedics will receive $18 million in a settlement with Bank of America from an arbitration proceeding before FINRA. Immunomedics also agreed to dismiss the proceeding with prejudice, and it and the bank agreed to release...
08:00 , Jan 28, 2013 |  BC Week In Review  |  Company News

BAC, Life Technologies deal

Life Technologies acquired protein purification products company BAC, which said it will maintain its staff and locations in Naarden and Leiden, the Netherlands. Life Technologies said financial terms were not disclosed. BAC B.V. , Naarden,...